Skip to main content

Table 2 Comparison of clinical parameters and comorbidities in the both groups

From: Clinical characteristics and risk factors for mortality in COVID-19 inpatients in Birjand, Iran: a single-center retrospective study

Clinical parameters and comorbidities Discharged patients (n  =  298) Death (n  =  62) Total (n  =  360) p
Age (years)
 < 60 years 226 (75.7%) 17 (27.1%) 199 (55.2%) < 0.001
 > 60 years 72 (24.3%) 45 (72.9%) 161 (44.8%)
Sex
 Male 134 (45%) 37 (59.6%) 184 (51.0%) 0.023
 Female 164 (55%) 25 (40.4%) 176 (49.0%)
URS
 Yes 164 (55%) 53 (86.4%) 245 (68.2%) 0.033
 No 134 (45%) 9 (13.6%) 115 (31.8%)
Dyspnea
 Yes 113 (37.9%) 39 (62.6%) 169 (46.9%) < 0.001
 No 185 (62.1%) 23 (37.4%) 191 (51.9%)
Headache
 Yes 28 (9.3%) 7 (11.1%) 36 (10.0%) 0.072
 No 270 (90.7%) 55 (88.9%) 324 (90.0%)
Hypertension
 Yes 39 (12.9%) 29 (46.5%) 96 (26.8%) < 0.001
 No 259 (87.1%) 33 (53.5%) 263 (73.2%)
Diabetes
 Yes 24 (7.9%) 13 (20.2%) 47 (13.0%) < 0.001
 No 274 (92.1%) 49 (79.8%) 313 (87.0%)
Coronary heart disease
 Yes 9 (2.9%) 11 (17.5%) 32 (8.8%) 0.014
 No 289 (97.1%) 51 (82.5%) 328 (91.2%)
Pulmonary comorbidities
 Yes 15 (5%) 7 (12.1%) 29 (7.9%) 0.32
 No 283 (95%) 55 (87.9%) 331 (92.1%)
Time to admission (days)
 > 6 130 (43.6%) 43 (68.7%) 194 (54.0%) < 0.001
 ≤ 6 168 (56.4%) 19 (31.3%) 166 (46.0%)
Hospital days (days)
 > 7 249 (83.6%) 16 (26.3%) 215 (59.8%) < 0.001
 ≤ 7 48 (16.4%) 45 (73.7%) 144 (40.2%)
  1. URS upper respiratory symptoms; p p value